Is overreliance on short-acting β(2)-agonists associated with health risks in the older asthma population?

Recent Global Initiative for Asthma (GINA) recommendations reduce the role of short-acting β(2)-agonist (SABA) premised on the associated exacerbation risk. The widely accepted SABA risk profile is based on limited data described 30 years ago. This GINA paradigm shift demands an examination of SABA...

Descripción completa

Detalles Bibliográficos
Autores principales: To, Teresa, Zhu, Jingqin, Terebessy, Emilie, Zhang, Kimball, Gershon, Andrea S., Licskai, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958218/
https://www.ncbi.nlm.nih.gov/pubmed/35350274
http://dx.doi.org/10.1183/23120541.00032-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958218/
https://www.ncbi.nlm.nih.gov/pubmed/35350274
http://dx.doi.org/10.1183/23120541.00032-2022

Ejemplares similares